iifl-logo

Invesco India Pharma and Healthcare Fund Regular G

Invesco India Pharma and Healthcare Fund Regular G

Fund Name

:  Invesco Mutual Fund

Scheme Name

:  Invesco India Pharma and Healthcare Fund Regular G

AMC

:  Invesco Mutual Fund

Type

:  Open

Category

:  Equity - Pharma

Launch Date

:  18-Aug-2026

Fund Manager

:  Taher Badshah

Net Assets (Rs. cr)

:  435.52

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Invesco India Pharma and Healthcare Fund Regular G - Nav Details

Nav Date

:  11-Nov-2026

NAV [Rs.]

:  10.5

Buy/Resale Price [Rs.]

:  0

Sell/Repurchase Price [Rs.]

:  0

Entry Load %

:  Nil

Exit Load %

:  If units are redeemed/switched out on or before 3 months from the date of allotment: 0.50% If units are redeemed/switched-out after 3 months: Nil Switch between the Plans under the Scheme: Nil

Invesco India Pharma and Healthcare Fund Regular G- NAV Chart

Invesco India Pharma and Healthcare Fund Regular G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
5
12.17
-
-
-
-
-
5
Category Avg
3.73
8.11
2.59
13.64
20.69
21.57
16.05
17.31
Category Best
5
12.26
6.6
20.29
32.91
31.09
20.6
31.5
Category Worst
2.45
5.96
-1
6.62
5.56
15.87
13.11
5

Invesco India Pharma and Healthcare Fund Regular G- Latest Dividends

No Records Found

Invesco India Pharma and Healthcare Fund Regular G- Investment Details

Min. Investment(Rs.)

:  1000

Increm.Investment(Rs.)

:  1000

In & Out

In

InName Of The CompanyNo Of Shares
Sahajanand Medi7,52,003
Mankind Pharma38,784

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityApollo HospitalsHealthcare Services9.085115443.21
EquityDivi's Lab.Pharmaceuticals & Biotechnology8.744250341.56
EquityMax HealthcareHealthcare Services8.5947551440.89
EquitySai LifePharmaceuticals & Biotechnology8.4925945040.40
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology8.3122244539.54
EquityManipal HealthHealthcare Services7.9756697237.93
EquityDr Agarwal's HeaHealthcare Services7.9374100037.73
EquitySahajanand MediHealthcare Equipment & Supplies7.3175200334.79
EquityGlobal HealthHealthcare Services5.9622324428.35
EquityCorona RemediesPharmaceuticals & Biotechnology5.7612754327.41
EquityGlenmark Pharma.Pharmaceuticals & Biotechnology4.489279621.33
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.424558821.03
EquityKrishna Institu.Healthcare Services4.3829682220.83
EquityAster DM QualityHealthcare Services3.5925103017.09
EquityMankind PharmaPharmaceuticals & Biotechnology2.03387849.66

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Invesco Mutual Fund
Incorporation Date:
20-May-2005
Total Assets Managed (Cr.):
1,65,374.86
Trustee/s:
Mr. Jeremy Simpson, Mr. Jeremy Charles Simpso, Invesco Trustee Private L
Chairman:
NA
CEO / MD:
Saurabh Nanavati
CIO:
NA
President:
NA
Director/s:
Andrew Tak Shing LO, Prakash Bhogale
Compliance Officer/s:
Suresh Jakhotiya
Investor Service Officer/s:
Surinder Singh Negi
Fund Manager/s:
Taher Badshah
Auditors:
NA

OTHER INFORMATION

Registered Office:
2101-A, A Wing, 21st Floor, Marathon Futurex, N.M.Joshi Marg, Lower Parel, Mumbai 400 013.
Contact Nos:
022 - 67310000
Fax:
022 - 23019422
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.